XCR Diagnostics Inc

Salt Lake City, UT · Founded 2015 · Medtech · Private

Xtreme Chain Reaction (XCR®) nucleic acid amplification chemistry combined with Pyramid portable testing system for near-patient molecular diagnostics

Claim this profile

Follows are private to you and power your alerts

Updated · xcrdiagnostics.com

Sector
Medtech
Headquarters
Salt Lake City, UT
Founded
2015
Latest Form D
$1.8M, Oct 2019
Total capital
$1.8M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$1.8M
2 Form D · last Oct 2019
84 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
3 pending · first 2020
Rank in peer group#425 of 1112

Capital timeline

20152016201720182019FEDERAL ↑EQUITY ↓Cumulative $3.8M1st Form D$2M2nd Form D$1.8M
20152016201720182019FEDERAL ↑EQUITY ↓Cumulative $3.8M1st Form D$2M2nd Form D$1.8M

Latest events

  • Private capital raisedForm D · SEC · 2nd filing$1.8M
  • Offering registeredForm D · SEC · 1st filing$2M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#425 · top 38%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Brian C CaplinResearcherExecutive Officer, PromoterLinked by 2 patents
  • Ann Marie C BuoscioExecutive OfficerNamed in SEC Form D filings
  • Linda C MerrillDirectorNamed in SEC Form D filings
  • Mark C BagnallDirectorNamed in SEC Form D filings
  • Mark PowelsonExecutive Officer, DirectorNamed in SEC Form D filings
  • William C OlsonExecutive Officer, Director, PromoterNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 5
Show all 5 patent records
  • Chemical Indicator Device With Heat BlocksApr 5, 2022 · US 11,293,855Granted
  • Dna Amplification TechnologyMar 11, 2021 · Application 16855776Pending
  • Multiplex ProbesJun 4, 2020 · Application 16503222Pending
  • Dna Amplification TechnologyJun 2, 2020 · US 10,669,574Granted
  • Dynamic Flux Nucleic Acid Sequence AmplificationSep 5, 2019 · Application 16415846Pending
  • Flexion TherapeuticsSimilar federal contract value in Medtech · null in contracts
  • Light in the Tunnel LLCSimilar federal contract value in Medtech · null in contracts
  • Lite Run, Inc.Similar federal contract value in Medtech · null in contracts
  • Cordex Systems, IncSimilar federal contract value in Medtech · null in contracts
  • ActivArmor LLCSimilar federal contract value in Medtech · null in contracts
  • Vantix Diagnostics, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .